The Latest Headlines at The Cerbat Gem
Royalty Pharma PLC (NASDAQ:RPRX) Receives Average Recommendation of “Buy” from Analysts
Royalty Pharma PLC (NASDAQ:RPRX – Get Free Report) has earned a consensus rating of “Buy” from the seven research firms that are presently covering the company, MarketBeat Ratings reports. Seven analysts have rated... More of this article »
Century Therapeutics, Inc. (NASDAQ:IPSC) Receives Consensus Rating of “Hold” from Analysts
Shares of Century Therapeutics, Inc. (NASDAQ:IPSC – Get Free Report) have earned an average rating of “Hold” from the seven ratings firms that are currently covering the stock, Marketbeat Ratings reports. One analyst... More of this article »
CNO Financial Group, Inc. (NYSE:CNO) Receives Consensus Rating of “Moderate Buy” from Brokerages
CNO Financial Group, Inc. (NYSE:CNO – Get Free Report) has been given an average recommendation of “Moderate Buy” by the five analysts that are presently covering the company, MarketBeat Ratings reports. Two research... More of this article »
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Consensus Recommendation of “Moderate Buy” by Analysts
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the company, Marketbeat reports. One equities research analyst... More of this article »
DaVita Inc. (NYSE:DVA) Receives Average Rating of “Hold” from Analysts
DaVita Inc. (NYSE:DVA – Get Free Report) has received an average rating of “Hold” from the eight ratings firms that are presently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the... More of this article »
Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives Consensus Recommendation of “Hold” from Brokerages
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Get Free Report) has received a consensus rating of “Hold” from the seven ratings firms that are covering the firm, MarketBeat Ratings reports. Two analysts have rated... More of this article »
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Rating of “Moderate Buy” from Brokerages
Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the four analysts that are covering the stock, MarketBeat reports. One analyst has rated... More of this article »
Nisun International Enterprise Development Group (NASDAQ:AIOS) versus Elmet Group (NASDAQ:ELMT) Head-To-Head Contrast
Elmet Group (NASDAQ:ELMT – Get Free Report) and Nisun International Enterprise Development Group (NASDAQ:AIOS – Get Free Report) are both small-cap construction companies, but which is the better investment? We will contrast... More of this article »
Chartwell Retirement Residences (TSE:CSH.UN) Given Consensus Recommendation of “Buy” by Brokerages
Chartwell Retirement Residences (TSE:CSH.UN – Get Free Report) has been assigned an average rating of “Buy” from the ten brokerages that are presently covering the company, MarketBeat.com reports. Nine research analysts... More of this article »
CeriBell, Inc. (NASDAQ:CBLL) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Shares of CeriBell, Inc. (NASDAQ:CBLL – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the six analysts that are currently covering the stock, Marketbeat reports. One analyst has... More of this article »
KORU Medical Systems, Inc. (NASDAQ:KRMD) Receives Average Recommendation of “Moderate Buy” from Brokerages
KORU Medical Systems, Inc. (NASDAQ:KRMD – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the stock, MarketBeat reports. One equities research... More of this article »
LKQ Corporation (NASDAQ:LKQ) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of LKQ Corporation (NASDAQ:LKQ – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the firm, Marketbeat.com reports. Three... More of this article »
Adicet Bio, Inc. (NASDAQ:ACET) Receives Average Rating of “Moderate Buy” from Brokerages
Adicet Bio, Inc. (NASDAQ:ACET – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the eight ratings firms that are covering the company, Marketbeat.com reports. One analyst has... More of this article »
